Abstract P5-04-02: Serum thymidine kinase 1 activity as a pharmacodynamics marker of cyclin-dependent kinase 4/6 inhibition in patients with early stage breast cancer receiving neoadjuvant palbociclib

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

Breast Cancer Research ◽

10.1186/s13058-017-0913-7 ◽

2017 ◽

Vol 19 (1) ◽

Cited By ~ 18

Author(s):

Nusayba Bagegni ◽

Shana Thomas ◽

Ning Liu ◽

Jingqin Luo ◽

Jeremy Hoog ◽

...

Keyword(s):

Breast Cancer ◽

Thymidine Kinase ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Cyclin Dependent Kinase ◽

Thymidine Kinase 1 ◽

Pharmacodynamic Marker ◽

Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer

ESMO Open ◽

10.1016/j.esmoop.2021.100076 ◽

2021 ◽

Vol 6 (2) ◽

pp. 100076

Author(s):

A. Matikas ◽

K. Wang ◽

E. Lagoudaki ◽

B. Acs ◽

I. Zerdes ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Thymidine Kinase ◽

Early Breast Cancer ◽

Prognostic Role ◽

Thymidine Kinase 1 ◽

Abstract P5-06-11: Serum thymidine kinase-1 activity (TKa) as a prognostic marker in premenopausal women with hormone receptor positive (HR+) operable breast cancer (BC)

10.1158/1538-7445.sabcs19-p5-06-11 ◽

2020 ◽

Author(s):

Luca Malorni ◽

Ilenia Migliaccio ◽

Chiara Biagioni ◽

Lorenzo Rossi ◽

Irene De Santo ◽

...

Keyword(s):

Breast Cancer ◽

Thymidine Kinase ◽

Prognostic Marker ◽

Hormone Receptor ◽

Premenopausal Women ◽

Operable Breast Cancer ◽

Thymidine Kinase 1 ◽

Role of serum thymidine kinase-1 (TK1) activity in patients (pts) with hormone receptor positive (HR+) advanced breast cancer (ABC) treated with endocrine therapy (ET) in the EFECT trial.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.12031 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 12031-12031 ◽

Cited By ~ 1

Author(s):

Luca Malorni ◽

Chiara Biagioni ◽

Amelia McCartney ◽

Gaia Schiavon ◽

Mattias Bergqvist ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Thymidine Kinase ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Advanced Breast ◽

Thymidine Kinase 1 ◽

292P Serum thymidine kinase 1 activity in patients with hormone receptor positive (HR+)/HER2 negative (HER2-) advanced breast cancer (aBC) treated in first-line with ribociclib (R) and letrozole (L) in the BioItaLEE trial

Annals of Oncology ◽

10.1016/j.annonc.2021.08.575 ◽

2021 ◽

Vol 32 ◽

pp. S492

Author(s):

L. Malorni ◽

M. De Laurentiis ◽

G. Bianchini ◽

A. Zambelli ◽

F. Puglisi ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Thymidine Kinase ◽

Hormone Receptor ◽

Advanced Breast ◽

Thymidine Kinase 1 ◽

First Line ◽

Abstract PS12-02: Safety and efficacy of an alternative schedule of palbociclib (PAL) in hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) and the utility of serum thymidine kinase 1 (sTK1) activity in predicting PAL response

10.1158/1538-7445.sabcs20-ps12-02 ◽

2021 ◽

Author(s):

Jairam Krishnamurthy ◽

Jingqin Luo ◽

Rama Suresh ◽

Foluso Ademuyiwa ◽

Caron Rigden ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Thymidine Kinase ◽

Hormone Receptor ◽

Metastatic Breast ◽

Thymidine Kinase 1 ◽

Safety And Efficacy ◽

Alternative Schedule ◽

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-21-1562 ◽

2021 ◽

Author(s):

Costanza Paoletti ◽

William E. Barlow ◽

Erin F. Cobain ◽

Mattias Bergqvist ◽

Rita S. Mehta ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Thymidine Kinase ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Metastatic Breast ◽

Thymidine Kinase 1 ◽

First Line ◽

1462 POSTER BRCA 1/2 Mutation Carriage in Healthy Women and Patients With Breast Cancer is Associated With Elevated Serum Thymidine Kinase 1 Activity

European Journal of Cancer ◽

10.1016/s0959-8049(11)70955-8 ◽

2011 ◽

Vol 47 ◽

pp. S187-S188

Author(s):

B. Nisman ◽

L. Kaduri ◽

T. Allweis ◽

T. Hamburger ◽

E. Carmon ◽

...

Keyword(s):

Breast Cancer ◽

Thymidine Kinase ◽

Elevated Serum ◽

Thymidine Kinase 1 ◽

Healthy Women ◽

Brca 1 ◽

Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume

BMC Cancer ◽

10.1186/s12885-020-06925-y ◽

2020 ◽

Vol 20 (1) ◽

Cited By ~ 1

Author(s):

Bernhard Tribukait

Keyword(s):

Breast Cancer ◽

Thymidine Kinase ◽

Neoadjuvant Treatment ◽

Cell Loss ◽

Tumour Volume ◽

Pathologic Response ◽

Early Prediction ◽

Thymidine Kinase 1 ◽

A Cell ◽

Serum thymidine kinase 1 activity in breast cancer

Cancer Biomarkers ◽

10.3233/cbm-2010-0148 ◽

2010 ◽

Vol 7 (2) ◽

pp. 65-72 ◽

Cited By ~ 25

Author(s):

Benjamin Nisman ◽

Tanir Allweis ◽

Luna Kaduri ◽

Bella Maly ◽

Simon Gronowitz ◽

...

Keyword(s):

Breast Cancer ◽

Thymidine Kinase ◽

Thymidine Kinase 1 ◽